Does DOXORUBICIN Cause Diffuse large b-cell lymphoma refractory? 345 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 345 reports of Diffuse large b-cell lymphoma refractory have been filed in association with DOXORUBICIN (Doxorubicin Hydrochloride). This represents 0.4% of all adverse event reports for DOXORUBICIN.
345
Reports of Diffuse large b-cell lymphoma refractory with DOXORUBICIN
0.4%
of all DOXORUBICIN reports
37
Deaths
62
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma refractory From DOXORUBICIN?
Of the 345 reports, 37 (10.7%) resulted in death, 62 (18.0%) required hospitalization, and 7 (2.0%) were considered life-threatening.
Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DOXORUBICIN. However, 345 reports have been filed with the FAERS database.
What Other Side Effects Does DOXORUBICIN Cause?
Febrile neutropenia (8,844)
Off label use (7,858)
Disease progression (6,165)
Neutropenia (5,891)
Drug ineffective (4,598)
Pyrexia (3,697)
Thrombocytopenia (3,638)
Anaemia (3,601)
Product use in unapproved indication (3,502)
Nausea (2,925)
What Other Drugs Cause Diffuse large b-cell lymphoma refractory?
RITUXIMAB (461)
CYCLOPHOSPHAMIDE (360)
VINCRISTINE (331)
ETOPOSIDE (244)
PREDNISONE (214)
EPCORITAMAB-BYSP (198)
CYTARABINE (193)
DEXAMETHASONE (170)
CISPLATIN (156)
IFOSFAMIDE (154)
Which DOXORUBICIN Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?
DOXORUBICIN vs DOXYCYCLINE
DOXORUBICIN vs DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYCYCLINE\DOXYCYCLINE HYCLATE
DOXORUBICIN vs DOXYLAMINE
DOXORUBICIN vs DOXYLAMINE\PYRIDOXINE